Ramazan TOPSAKAL, Saban KELESOGLU, Aydin TUNCAY, Deniz ELCİK, Abdurrahman OGUZHAN, Ali DOGAN, Zeki CETİNKAYA, Serhat KARADAVUT, Mehmet Tugrul INANC

Flow-Mediated Vasodilatation which is diagnostic method of endothelial dysfunctions change in atrial septal defect patients before and after closure of the ASD

AbstractAim: Atrial septal defect secondary pulmonary hypertension causes disruption of the endothelial structure, resulting in an increase in vasoconstrictor mediators and a decrease in vasodilator mediators. These changes on the endothelial system alter the flow in the pulmonary vein and the systemic vein bed. This also has an effect on flow mediated vasodilatation. Our purpose in this study is to evaluate the endothelial dysfunction after atrial septal defect closure via flow mediated vasodilatation.Material and Methods: Total 51 patients with pre and one mount after post treatment secundum-type atrial septal defect and 40 healthy volunteers were prospectively enrolled. Atrial septal defect was treated with transcathater closure procedure. Flow mediated vasodilatation was measured to evaluate endothelial function prior to and one month after the defect was closured.Results: Flow-mediated vasodilatation values were significantly higher in an atrial septal defect′s patient than in the healthy volunteer (11.2 ± 1.01 m/s vs. 12.7 ± 1.18 m/s, P < 0.001). Flow-mediated vasodilatation values were significantly reduced at the follow-up one month after the procedure compared to baseline. Moreover, there was a significant negative correlation between pulmonary arterial pressure values and flow-mediated vasodilatation (r=-0.347; p=0.013) in the pretreatment group.Conclusion: Flow-mediated vasodilatation values were significantly lower in the right cardiac chambers, and the systolic pulmonary arterial pressure was improved. This result has shown us that atrial septal defect closure may benefit from endothelial dysfunction.

PDF

___

1. Therrien J, Webb GD. Congenital heart disease in adults. In: Braunwald E, Zipes DP, Libby P, editors. Braunwald’s heart disease: a textbook of cardiovascular medicine. 6th ed. Philadelphia: W. B. Saunders 2001;1592-621.
2. Gatzoulis MA, Redington AN, Somerville J, et al. Should atrial septal defects in adults be closed? Ann ThoracSurg 1996;61:657-9.
3. Pascotto M, Santoro G, Cerrato F, et al. Time-course of cardiac remodeling following transcatheter closure of atrial septal defect. Int J Cardiol2006;112:348-52.
4. Zipes DP, Libby P, Braunwald E. Pulmonary Hypertension. In: Heart disease: a textbook of cardiovascular medicine. 7 th ed. Philadelphia: Elsevier Science 2004;1807-43.
5. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109:159-65.
6. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-6.
7. Corretti MC, Anderson TJ, Benjamin EJ, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65.
8. Lang RM, Bierig M, Devereux RB, et al. American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
9. Berger F, Ewert P, Bjornstad PG, et al. Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer septal occluder. Cardiol Young 9:468-73
10. Du ZD, Hijazi ZM, Kleinman CS, et al. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am CollCardiol 39:1936-44.
11. de Beco G, Duisit J, Poncelet AJ. Heart transplantation using a donor with partial anomalous pulmonary venous connection and atrial septal defect. Interact Cardiovasc Thorac Surg. 2017;24:978-9.
12. Charakida M, Masi S, Lüscher TF, et al. Assessment of atherosclerosis: the role of flow-mediated dilatation. EurHeart J 2010;31:2854-61.
13. Vogel M, Berger F, Kramer A, et al.Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart 1999;82:30-3
14. Sachweh JS, Daebritz SH, Hermanns B, et al. Hypertensive pulmonary vascular disease in adults with secundum or sinus venosus atrial septal defect. Ann Thorac Surg 2006;81:207-13.
15. Balint OH, Samman A, Haberer K, et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart 2008 ;94:1189-93.
16. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007;115:1285-95.
17. Celermajer DS, Sorensen KE, Gooch VM, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
18. Lu H, Chen S, Wang H, Cheng P. Role of adrenomedullin in congenital heart disease associated with pulmonary hypertension J Huazhong Univ Sci Technolog Med Sci 2003;23:275-7.
19. Stewart DJ, Levy RD, Cernacek P, et al. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 1991; 114:464-9.
20. Cesar LA, Ramires JA, Serana Junior CV, et al. Slow coronary runoffİn patient with angina pectoris: clinical significance and thalium–201 scintigraphic study. Braz Med Biol Res 1996;29:605-13.
21. Kaya MG, Ozdoğru I, Baykan A, et al. Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder in adult patients: our first clinical experiences Turk Kardiyol Dern Ars 2008;36:287-93.